Minocycline-induced hyperpigmentation: Comparison of 3 Q-switched lasers to reverse its effects

Clinical, Cosmetic and Investigational Dermatology

Volumn 6, Issue , 2013, Pages 159-162

  Nisar, Mahrukh S ^a   Iyer, Karthik ^a   Brodell, Robert T ^b   Lloyd, Jenifer R ^c   Shin, Thuzar M ^c   Ahmad, Asad ^d  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Northside Medical Center   (United States)

Author keywords

Antibiotic; Discoloration; Inflammatory disease; Rheumatoid arthritis; Tetracycline; Wavelength

Indexed keywords

MINOCYCLINE;

AGED; ALEXANDRITE LASER; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FACE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INTERMETHOD COMPARISON; LYMPHOCYTIC INFILTRATION; MALE; NEODYMIUM YAG LASER; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PUNCH BIOPSY; RHEUMATOID ARTHRITIS; RUBY LASER; SOLID STATE LASER; SUNLIGHT PROTECTION; TREATMENT RESPONSE;

EID: 84878473417     PISSN: 11787015     EISSN: None     Source Type: Journal    
DOI: 10.2147/CCID.S42166     Document Type: Article

References (15)

1. Merchant F, Carpenter T. Blue-gray discoloration of the skin. Am Fam Physician. October 1, 2011;84(7):821-8222.
2. Kalia S, Adams SP, Dermcase. Minocycline-induced pigmentation. Can Family Physician. May 2006;52:595-596.
3. Pecina JL, Pittelkow MR. Hyperpigmentation - a case study. Aust Fam Physician. Sep 2011;40(9):701-702.
4. Eisen D, Hakim MD, Minocycline-induced pigmentation: Incidence, prevention, and management. Drug Saf. Jun 1998;18(6):431-440.
5. Mouton RW, Jordaan HF, Schneider JW. A new type of minocycline-induced cutaneous hyperpigmentation. Clin Exp Dermatol. Jan 2004; 29(1):8-14.
6. Green D, Friedman KJ. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol. Feb 2001;44(Suppl 2):342-347.
7. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol. Apr 1996;134(4):693-695.
8. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol. Oct 1996;132(10):1251-1253.
9. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. Oct 1996;132(10):1250-1251.
10. Ruth C. Running on empty. FDA, Congress working to mitigate drug shortages. Derm World. Jul 2012.
11. Samalonis LB. Q-switched lasers effective for treating drug-induced hyperpigmentation. Dermatology Times. March 1, 2012.
12. Holm AN, Nelson WK. Images in clinical medicine. Minocycline-induced hyperpigmentation. N Engl J Med. November 16, 2006;355(20):e23.
13. Wiper A, Roberts DH, Schmitt M. Amiodarone-induced skin pigmentation: Q-switched laser therapy, an effective treatment option. Heart. Jan 2007;93(1):15.
14. Gupta LK, Tanwar RK, Khare AK, Jain SK. Bleomycin induced flagellate pigmentation. Indian J Dermatol Venereol Leprol. May-Jun 2002;68(3):158-159.
15. Greenberg RG, Berger TG. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. J Am Acad Dermatol. Feb 1990;22(2 Pt 2):327-330.